NEW YORK - Billionaire investor Carl Icahn reported a new stake in Amylin Pharmaceuticals Inc. as of March 31, but no longer owned shares of department store chain Macy's Inc. and railroad operator CSX Corp., according to a quarterly regulatory filing Thursday.
In the Securities and Exchange Commission filing, Icahn reported holding 6.3 million shares of Amylin, a San Diego-based biopharmaceutical company. The investor had reported stakes in Macy's and CSX and in his fourth-quarter regulatory filing but did not report holdings in this most recent report.
He no longer holds shares of insurance provider Unum Group, Canadian energy company Compton Petroleum Corp. and insurance and investment manager Lincoln National Corp., as well.
In addition, Icahn no longer reported owning a stake in "Grand Theft Auto" publisher Take-Two Interactive Software Inc. Electronic Arts Inc. made a $2 billion offer to buy the video game publisher in February. The bid expires on Friday. Take-Two has said the price is too low.
The investor also reported boosting his stakes in Biogen Idec Inc., Enzon Pharmaceuticals Inc., Forestar Real Estate Group Inc., Guaranty Financial Group Inc. and Motorola Inc. during the quarter. He lowered his holdings in Perry Ellis International Inc., J.C. Penney Co. and Williams Cos.

The above adage is well known by precious-metals investors; in fact I used this quote in one of our monthly reports. I recall how many inquiries ...
The review was scathing. "She cannot sing very well," it said. "She is flat a go...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...


Professional Website Design For Corporate - Get a Free Quote Today